Effect of an acidic pyruvate-based peritoneal dialysis solution on the pH of a residual peritoneal dialysate fluid

Artificial Organs

Volumn 20, Issue 3, 1996, Pages 264-266

  Ing, T S ^a   Yang, M L ^b   Yang, V L ^b   Wong, F K M ^b   Cheng, Y L ^b   Guddeti, S R ^b   Yu, A W ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Acidic; Lactate; Peritoneal dialysis solution; pH; Pyruvate; Residual fluid

Indexed keywords

ACIDIC; ACIDIC PH; DIALYSATES; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS SOLUTION; PYRUVATES; RESIDUAL FLUIDS; SOLUTION MIXTURES;

PERITONEAL DIALYSIS FLUID; PYRUVIC ACID; DIALYSIS FLUID; LACTIC ACID; LACTIC ACID DERIVATIVE; PYRUVIC ACID DERIVATIVE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PH; PRIORITY JOURNAL; ASCITES FLUID; CHEMISTRY; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; METABOLISM;

ASCITIC FLUID; DIALYSIS SOLUTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY FAILURE, CHRONIC; LACTATES; LACTIC ACID; MALE; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PYRUVATES;

EID: 0030100186     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1996.tb04436.x     Document Type: Article

References (23)

1. Daugirdas JT, Ing TS, Gandhi VC, Hano JE, Chen WT, Yuan L. Kinetics of peritoneal fluid absorption in patients with chronic renal failure. J Lab Clin Med 1980;7:138-47.
2. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, Nielsen MP. Peritoneal equilibration tests. Perit Dial Bull 1987;7:138-47.
3. Ahmed MI, Rawal PA, Patel NM, Yu AW, Abraham M, Harvey VC, Ing TS. In vitro buffering capacity of residual peritoneal dialysate fluid: Implications for peritoneal dialysis. Artif Organs 1992;16:416-7.
4. Brunkhorst B, Mahiout A. Pyruvate as non-toxic peritoneal dialysate (PD) buffer: maintained mesothelial cell (MC) integrity and proliferation (abstract). J Am Sac Nephrol 1994; 5:410.
5. Mahiout A, Brunkhorst R. Development of a new CAPD solution using the anion pyruvate as buffer improving peritoneal host defence (abstract). J Am Soc Nephrol 1994;5: 421.
6. Mahiout A, Brunkhorst R. Pyruvate anions neutralize peritoneal dialysate cytotoxicity. Nephrol Dial Transplant 1995; 10:391-4.
7. Ing TS, Yu AW, Guddeti SR, Sekhri R, Yang ML, Zhou FQ. An acidic, pyruvate-based peritoneal dialysis solution (PDS) lowers the pH of a residual peritoneal dialysate fluid to a less extent than does an equally acidic, lactate-based counterpart (abstract). 41st Annual Meeting of the American Society of Artificial Internal Organs Abstracts Book 1995;24:101.
8. Personel communications from Baxter Healthcare Corporation, Deerfield, Illinois, U.S.A.
9. Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry, 2nd Ed. Philadelphia: W.B. Saunders Company, 1994:2169.
10. Reynolds JEF, ed. The extra pharmacopoeia, 13th Ed. London: The Pharmaceutical Press, 1993:23.
11. Murray RK, Granner DK, Mayes PA, Rodwell VW, eds. Harper's biochemistry. 23rd Ed. East Norwalk, Connecticut: Appleton & Lange, 1993:15-21, 164-80.
12. Ing TS, Wong FKM, Yang ML, Yu AW, Bunnapradist S, Zhou FQ. Acidic, pyruvate-based peritoneal dialysis solutions: relationship between low titratable acidity and biocompatibility. Int J Artif Organs 1995;18:111-2.
13. Yu AW, Zhou XJ, Zhou FQ, Nawab ZM, Gandhi VC, Ing TS, Vaziri ND. Neutrophilic intracellular acidosis induced by conventional, lactate-containing peritoneal dialysis solutions. Int J Artif Organs 1992;15:661-5.
14. Zhou XJ, Yu AW, Zhou FQ, Ryu J, Ing TS, Vaziri ND. Effects of an acidic, lactate-based peritoneal dialysis solution and its euhydric, bicarbonate-based counterpart on neutrophilic intracellular pH. Int J Artif Organs 1993;16:816-9.
15. Liberek T, Topley N, Jorres A, Petersen MM, Coles GA, Gahl GM, Williams JD. Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 1993; 65:260-5.
16. Duwe AK, Vas SI, Weatherhead JW. Effect of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis and bactericidal activity in vitro. Infect Immunol 1981;33:130-5.
17. Ing BL, Gupta DK, Nawab ZM, Zhou FQ, Rahman MA, Daugirdas JT. Suppression of neutrophil superoxide production by conventional peritoneal dialysis solution. Int J Artif Organs 1988;11:351-4.
18. Topley N, Alobaidi HMM, Davies M, Coles GA, Williams JD, Lloyd D. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988;34:404-11.
19. Ing TS, Zhou XJ, Yu AW, Zhou FQ, Vaziri ND. Lactate-containing peritoneal dialysis solution. Int J Artif Organs 1993;16:688-93.
20. Jorres A, Topley N, Gahl GM. Biocompatibility of peritoneal dialysis fluids. Int J Artif Organs 1992;15:79-83.
21. Dobos GJ, Andre M, Bohler J, Norgauer J, Lubrich-Birkner I, Steinhauer HB, Schollmeyer PJ. Inhibition of C5a-induced actin polymerization, chemotaxis, and phagocytosis of human polymorphonuclear neutrophils incubated in a glucose-based dialysis solution. Adv Peril Dial 1993;9:307-11.
22. Ing TS, Huie DA, Johnson V, Ryu J, Yu AW, Wong FKM, Zhou FQ. Effects of lactate-based and bicarbonate-based peritoneal dialysis solutions on neutrophilic oxygen consumption. Artif Organs 1995;19:440-2.
23. Hartmann AF, Senn MJE. Studies in the metabolism of sodium r-lactate. I. Response of normal human subjects to the intravenous injection of sodium r-lactate. J Clin Invest 1932; 11:327-35.